Cryoport

Cryoport, Inc., trading as NASDAQ: CYRX, is a distinguished global provider of temperature-controlled supply chain solutions, established in 1999. The company specializes in critical logistics for the life sciences sector, with a pronounced focus on cell and gene therapies, biopharmaceuticals, animal health, and human reproductive medicine. As the world's largest manufacturer of cryogenic storage systems and a leading life science specialty courier, Cryoport supports a diverse clientele including biopharmaceutical firms, academic institutions, and research organizations worldwide. Its operations are underpinned by advanced packaging, specialized logistics, biostorage services, and cutting-edge informatics, ensuring the integrity of sensitive biological materials throughout transit.

Operating with a workforce of 500-1,000 employees across 3 locations, Cryoport offers a comprehensive suite of services designed to meet stringent industry demands. This includes sophisticated cryogenic equipment, specialty courier services, and end-to-end supply chain management platforms that provide complete visibility and condition monitoring for shipments. The company's expertise extends to direct-to-patient logistics and global cryogenic shipping, leveraging advanced technology for agile and compliant cold chain solutions. For insights into the dedicated professionals driving these operations, one can Meet Cryoport's team.

Cryoport's market presence is significant, positioning it among key players in the freight and logistics services and transportation industries. Its competitive landscape includes major entities such as Crane Worldwide Logistics, AIT Worldwide Logistics, and Traffic Tech, highlighting the dynamic nature of the global supply chain market. With a reported revenue of $182.9M, Cryoport demonstrates substantial operational scale and market penetration, continually innovating to address the evolving needs of the biopharmaceutical and researchView more...